* Refers to the technology and development partner’s ownership (TTP, via management structure).
The company has outstanding warrants of 95,202,981 and warrants for management and the board of 2,500,000 and 1,800,000 to Psyros employees that can entail 83,635,742,5 shares and can thus cause dilution.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.
Source: Euroclear